Inventor · disambiguated record
Paul Humphries
Also filed as: HUMPHRIES PAUL · HUMPHRIES PAUL S · HUMPHRIES PAUL STUART
15 granted patents·11 pending applications·48 citations·filing 2004–2025
91Inventor score
Files withBIOAGE LABS INC7RESET THERAPEUTICS INC5CENTESSA PHARMACEUTICALS UK LTD4OREXIA THERAPEUTICS LTD2SYCHRONICITY PHARMA INC2
Top patents by PatentIndex Score
26 records- 0193US11708334B2Inhibitors of NLRP3 inflammasomeBIOAGE LABS INC·Filed 2022·Granted Jul 25, 2023·3 cites·18 claims
- 0292US12215087B2Inhibitors of NLRP3 inflammasomeBIOAGE LABS INC·Filed 2023·Granted Feb 4, 2025·1 cites·6 claims
- 0391US7842713B2Fused phenyl amido heterocyclic compoundsPFIZER·Filed 2007·Granted Nov 30, 2010·13 cites·15 claims
- 0487US11702391B2Inhibitors of NLRP3 inflammasomeBIOAGE LABS INC·Filed 2022·Granted Jul 18, 2023·1 cites·9 claims
- 0586US10214507B2Carbazole-containing amides, carbamates, and ureas as cryptochrome modulatorsRESET THERAPEUTICS INC·Filed 2018·Granted Feb 26, 2019·5 cites·22 claims
- 0686US10005759B2Carbazole-containing amides, carbamates, and ureas as cryptochrome modulatorsRESET THERAPEUTICS INC·Filed 2015·Granted Jun 26, 2018·6 cites·39 claims
- 0784US9265772B2Carbazole-containing sulfonamides as cryptochrome modulatorsRESET THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·9 cites·22 claims
- 0883US12421196B2Inhibitors of NLRP3 inflammasomeBIOAGE LABS INC·Filed 2023·Granted Sep 23, 2025·0 cites·18 claims
- 0982US10759777B2Carbazole-containing amides, carbamates, and ureas as cryptochrome modulatorsSYNCHRONICITY PHARMA INC·Filed 2018·Granted Sep 1, 2020·2 cites·27 claims
- 1081US9775845B2Carbazole-containing sulfonamides as cryptochrome modulatorsRESET THERAPEUTICS INC·Filed 2016·Granted Oct 3, 2017·4 cites·11 claims
- 1181US2024190837A1Carbazole-containing amides, carbamates, and ureas as cryptochrome modulatorsSYCHRONICITY PHARMA INC·Filed 2023·Application pending·0 cites
- 1281US2023365507A1Inhibitors of nlrp3 inflammasomeBIOAGE LABS INC·Filed 2023·Application pending·0 cites
- 1377US12435043B2Inhibitors of NLRP3 inflammasomeHARTMAN GEORGE·Filed 2023·Granted Oct 7, 2025·0 cites·15 claims
- 1475US8119624B2Fused phenyl amido heterocyclic compoundsBAI HAO·Filed 2010·Granted Feb 21, 2012·4 cites·7 claims
- 1574US2025236629A1Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related usesCENTESSA PHARMACEUTICALS UK LTD·Filed 2024·Application pending·0 cites
- 1674US2022411399A1Carbazole-containing amides, carbamates, and ureas as cryptochrome modulatorsSYCHRONICITY PHARMA INC·Filed 2022·Application pending·0 cites
- 1767US2025100968A1Bicyclic-heterocycle derivatives and related usesCENTESSA PHARMACEUTICALS UK LTD·Filed 2024·Application pending·0 cites
- 1865US2025155452A1NLRP3 Variants & Library Screen for NLRP3 Inhibitors with the SameBIOAGE LABS INC·Filed 2024·Application pending·0 cites
- 1965US2021171495A1Carbazole-containing amides, carbamates, and ureas as cryptochrome modulatorsSYNCHRONICITY PHARMA INC·Filed 2020·Application pending·0 cites
- 2063US2025289828A1Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related usesCENTESSA PHARMACEUTICALS UK LTD·Filed 2025·Application pending·0 cites
- 2158US2024239744A12-(3-ethynylbenzyl)-substituted heterocycle derivatives and related usesOREXIA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2255US2023331720A1Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonistsOREXIA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2352US12503475B2Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonistsCENTESSA PHARMACEUTICALS UK LTD·Filed 2021·Granted Dec 23, 2025·0 cites·20 claims
- 2451US10383880B2Carbazole-containing sulfonamides as cryptochrome modulatorsRESET THERAPEUTICS INC·Filed 2017·Granted Aug 20, 2019·0 cites·8 claims
- 2545US12509459B2Inhibitors of NLRP3 inflammasomeBIOAGE LABS INC·Filed 2025·Granted Dec 30, 2025·0 cites·29 claims
- 2642US2005234066A1Alpha substituted carboxylic acidsAGOURON PHARMA·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →